You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東曜藥業-B(01875.HK):向28名承授人授出1370萬股獎勵股份
格隆匯 12-23 22:48

格隆匯12月23日丨東曜藥業-B(01875.HK)宣佈,其決議根據受限制股份獎勵計劃向28名承授人作出2021年年終授出,共涉及1370萬股獎勵股份,有關股份將根據一般授權配發及發行。董事會亦決議修訂計劃規則,涉及已不能歸屬或已失效的獎勵股份的處理方式,有關修訂不會對任何經選定參與者的任何現有權利造成不利影響。

與2021年年終授出有關的1370萬股獎勵股份佔(i)公司於公吿日期的已發行股本約2.28%;或(ii)公司經配發及發行有關獎勵股份所擴大的已發行股本約2.23%。公司將向聯交所上市委員會申請批准該等獎勵股份上市及買賣,預期有關股份將在取得聯交所批准後於2021年年底前配發及發行。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account